Mercury Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Mercury Laboratories has a total shareholder equity of ₹517.0M and total debt of ₹29.6M, which brings its debt-to-equity ratio to 5.7%. Its total assets and total liabilities are ₹694.3M and ₹177.3M respectively. Mercury Laboratories's EBIT is ₹50.3M making its interest coverage ratio 101.9. It has cash and short-term investments of ₹26.7M.
Key information
5.7%
Debt to equity ratio
₹29.57m
Debt
| Interest coverage ratio | 101.9x |
| Cash | ₹26.66m |
| Equity | ₹516.96m |
| Total liabilities | ₹177.35m |
| Total assets | ₹694.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 538964's short term assets (₹367.3M) exceed its short term liabilities (₹126.9M).
Long Term Liabilities: 538964's short term assets (₹367.3M) exceed its long term liabilities (₹50.4M).
Debt to Equity History and Analysis
Debt Level: 538964's net debt to equity ratio (0.6%) is considered satisfactory.
Reducing Debt: 538964's debt to equity ratio has reduced from 26.8% to 5.7% over the past 5 years.
Debt Coverage: 538964's debt is well covered by operating cash flow (300.8%).
Interest Coverage: 538964's interest payments on its debt are well covered by EBIT (101.9x coverage).